Literature DB >> 34073237

Current Advances on the Important Roles of Enhancer RNAs in Molecular Pathways of Cancer.

Rui Wang1, Qianzi Tang1.   

Abstract

Enhancers are critical genomic elements that can cooperate with promoters to regulate gene transcription in both normal and cancer cells. Recent studies reveal that enhancer regions are transcribed to produce a class of noncoding RNAs referred to as enhancer RNAs (eRNAs). Emerging evidence shows that eRNAs play important roles in enhancer activation and enhancer-driven gene regulation, and the expression of eRNAs may be a critical factor in tumorigenesis. The important roles of eRNAs in cancer signaling pathways are also gradually unveiled, providing a new insight into cancer therapy. Here, we review the roles of eRNAs in regulating cancer signaling pathways and discuss the potential of eRNA-targeted therapy for human cancers.

Entities:  

Keywords:  cancer signaling pathway; cancer therapy; eRNA

Year:  2021        PMID: 34073237     DOI: 10.3390/ijms22115640

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  61 in total

Review 1.  Shaping the nuclear action of NF-kappaB.

Authors:  Lin-Feng Chen; Warner C Greene
Journal:  Nat Rev Mol Cell Biol       Date:  2004-05       Impact factor: 94.444

2.  Inflammation-sensitive super enhancers form domains of coordinately regulated enhancer RNAs.

Authors:  Nasun Hah; Chris Benner; Ling-Wa Chong; Ruth T Yu; Michael Downes; Ronald M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-06       Impact factor: 11.205

Review 3.  Androgen receptor in prostate cancer.

Authors:  Cynthia A Heinlein; Chawnshang Chang
Journal:  Endocr Rev       Date:  2004-04       Impact factor: 19.871

4.  Activation of P-TEFb by Androgen Receptor-Regulated Enhancer RNAs in Castration-Resistant Prostate Cancer.

Authors:  Yu Zhao; Liguo Wang; Shancheng Ren; Lan Wang; Patrick R Blackburn; Melissa S McNulty; Xu Gao; Meng Qiao; Robert L Vessella; Manish Kohli; Jun Zhang; R Jeffrey Karnes; Donald J Tindall; Youngsoo Kim; Robert MacLeod; Stephen C Ekker; Tiebang Kang; Yinghao Sun; Haojie Huang
Journal:  Cell Rep       Date:  2016-04-07       Impact factor: 9.423

Review 5.  Regulation and function of NF-kappaB transcription factors in the immune system.

Authors:  Sivakumar Vallabhapurapu; Michael Karin
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

Review 6.  Dual-specificity MAP kinase phosphatases (MKPs): shaping the outcome of MAP kinase signalling.

Authors:  Christopher J Caunt; Stephen M Keyse
Journal:  FEBS J       Date:  2012-08-28       Impact factor: 5.542

7.  Divergent signalling pathways regulate lipopolysaccharide-induced eRNA expression in human monocytic THP1 cells.

Authors:  James A Heward; Benoit T Roux; Mark A Lindsay
Journal:  FEBS Lett       Date:  2014-12-29       Impact factor: 4.124

8.  Enhancer transcripts mark active estrogen receptor binding sites.

Authors:  Nasun Hah; Shino Murakami; Anusha Nagari; Charles G Danko; W Lee Kraus
Journal:  Genome Res       Date:  2013-05-01       Impact factor: 9.043

9.  Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLCε-NF-κB signaling pathway and VEGF-C/ Bcl-2 expression.

Authors:  Yunzhao Chen; Dandan Wang; Hao Peng; Xi Chen; Xueping Han; Jie Yu; Wenjie Wang; Lirong Liang; Zheng Liu; Yi Zheng; Jianming Hu; Lan Yang; Jun Li; Hong Zhou; Xiaobin Cui; Feng Li
Journal:  Mol Cancer       Date:  2019-01-04       Impact factor: 27.401

10.  Pharmacodynamic response and inhibition of growth of human tumor xenografts by the novel histone deacetylase inhibitor PXD101.

Authors:  Jane A Plumb; Paul W Finn; Robert J Williams; Morwenna J Bandara; M Rosario Romero; Claire J Watkins; Nicholas B La Thangue; Robert Brown
Journal:  Mol Cancer Ther       Date:  2003-08       Impact factor: 6.261

View more
  1 in total

1.  Enhancer RNA Profiling in Smoking and HPV Associated HNSCC Reveals Associations to Key Oncogenes.

Authors:  Neil Shende; Jingyue Xu; Wei Tse Li; Jeffrey Liu; Jaideep Chakladar; Kevin T Brumund; Weg M Ongkeko
Journal:  Int J Mol Sci       Date:  2021-11-21       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.